Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex

G Guillemette, S Lamontagne, G Boulay and B Mouillac

Department of Pharmacology, Faculty of Medicine, University of Sherbrooke, Quebec, Canada.

In a wide variety of cells, inositol-1,4,5-triphosphate is a second messenger that interacts with specific intracellular receptors and triggers the release of sequestered Ca2+ from an intracellular store. We have looked at the influence of heparin on the action and metabolism of inositol-1,4,5-triphosphate in the bovine adrenal cortex. Heparin blocked inositol-1,4,5-trisphosphate binding with half-maximal efficiency around 10 micrograms/ml. Scatchard analyses revealed that heparin did not change the affinity but decreased the number of available binding sites. The Ca2+-releasing activity of inositol-1,4,5- trisphosphate was monitored with the fluorescent indicator, fura-2. Heparin blocked this activity with half-maximal effeciency around 10 micrograms/ml. The effect of heparin could be overcome by a supramaximal dose of inositol-1,4,5-trisphosphate (25 microM). The activity of inositol-1,4,5-trisphosphate-3-kinase from bovine adrenal cortex cytosol was also studied. Heparin inhibited the activity of the kinase with a half-maximal effeciency around 0.4 microgram/ml. Lineweaver-Burk plots revealed that this potent effect was noncompetitive. Finally, we observed that heparin is without effect on inositol-1,4,5-trisphosphate-5-phosphatase (at concentrations as high as 2 mg/ml). These results are consistent with the suggestion that the binding sites for inositol-1,4,5-trisphosphate are the intracellular receptors responsible for the Ca2+-mobilizing effects of inositol-1,4,5- trisphosphate. These results also show that the kinase, the phosphatase, and the receptor are three different molecular entities, which are affected in a different manner by heparin.

Volume 35, Issue 3, pp. 339-344, 03/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				O. Krinke, Z. Novotna, O. Valentova, and J. Martinec Inositol trisphosphate receptor in higher plants: is it real? J. Exp. Bot., February 1, 2007; 58(3): 361 - 376. [Abstract] [Full Text] [PDF]

				R. Laporte, A. Hui, and I. Laher Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513. [Abstract] [Full Text] [PDF]

				F.-X. Boittin, N. Macrez, G. Halet, and J. Mironneau Norepinephrine-induced Ca2+ waves depend on InsP3 and ryanodine receptor activation in vascular myocytes Am J Physiol Cell Physiol, July 1, 1999; 277(1): C139 - C151. [Abstract] [Full Text] [PDF]

				N. Macrez, J.-L. Morel, and J. Mironneau Specific Galpha 11beta 3gamma 5 Protein Involvement in Endothelin Receptor-Induced Phosphatidylinositol Hydrolysis and Ca2+ Release in Rat Portal Vein Myocytes Mol. Pharmacol., April 1, 1999; 55(4): 684 - 692. [Abstract] [Full Text]

				M. Oz, M. T. Melia, N. M. Soldatov, D. R. Abernethy, and M. Morad Functional Coupling of Human L-Type Ca2+ Channels and Angiotensin AT1A Receptors Coexpressed in Xenopus laevis Oocytes: Involvement of the Carboxyl-Terminal Ca2+ Sensors Mol. Pharmacol., December 1, 1998; 54(6): 1106 - 1112. [Abstract] [Full Text]

				R. S. Mathias, K. Mikoshiba, T. Michikawa, A. Miyawaki, and H. E. Ives IP3 receptor blockade fails to prevent intracellular Ca2+ release by ET-1 and alpha -thrombin Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1456 - C1465. [Abstract] [Full Text] [PDF]

				C. T. Murphy, A. M. Riley, C. J. Lindley, D. J. Jenkins, J. Westwick, and B. V. L. Potter Structural Analogues of D-myo-Inositol-1,4,5-trisphosphate and Adenophostin A: Recognition by Cerebellar and Platelet Inositol-1,4,5-trisphosphate Receptors Mol. Pharmacol., October 1, 1997; 52(4): 741 - 748. [Abstract] [Full Text]

				J.-F.ço. Coquil, J.-P. Mauger, and M. Claret Inositol 1,4,5-Trisphosphate Slowly Converts Its Receptor to a State of Higher Affinity in Sheep Cerebellum Membranes J. Biol. Chem., February 16, 1996; 271(7): 3568 - 3574. [Abstract] [Full Text] [PDF]

				K. Maes, L. Missiaen, J. B. Parys, P. De Smet, I. Sienaert, E. Waelkens, G. Callewaert, and H. De Smedt Mapping of the ATP-binding Sites on Inositol 1,4,5-Trisphosphate Receptor Type 1 and Type 3 Homotetramers by Controlled Proteolysis and Photoaffinity Labeling J. Biol. Chem., January 26, 2001; 276(5): 3492 - 3497. [Abstract] [Full Text] [PDF]